Dotmatics

📍 Boston, United States👥 465 employees💰 Last funded Nov 2017
Software Development🌐 dotmatics.com
Website LinkedIn
Dotmatics is the global leader in R&D scientific software that connects science, data, and decision-making. Combining a workflow and data platform with best-of-breed applications, we offer the first true end-to-end solutions for biology, chemistry, formulations, data management, flow cytometry, and more. Trusted by more than 2 million researchers from the world’s leading biopharma, chemicals and materials enterprises, and academic institutions, we are dedicated to working with the scientific community to help make the world a healthier, cleaner and safer place to live. Learn more about our platform and products, including GraphPad Prism, Geneious, SnapGene, Protein Metrics, LabArchives, and more, at https://dotmatics.com.
3
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
3
Frequently asked questions
Who invested in Dotmatics?
Dotmatics has 3 investors on record on gritt.io.
When did Dotmatics last raise funding?
The most recent investment in Dotmatics recorded on gritt.io was in November 2017.
What industry is Dotmatics in?
Dotmatics operates in Software Development. Find similar Software Development investors on gritt.io.
Where is Dotmatics based?
Dotmatics is headquartered in Boston, United States.